BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26303610)

  • 1. Mucopolysaccharidosis (MPS) Physical Symptom Score: Development, Reliability, and Validity.
    Ahmed A; Rudser K; Kunin-Batson A; Delaney K; Whitley C; Shapiro E
    JIMD Rep; 2016; 26():61-8. PubMed ID: 26303610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying medical manifestations in Hurler syndrome with the infant physical symptom score: associations with long-term physical and adaptive outcomes.
    Ahmed A; Rudser K; King KE; Eisengart JB; Orchard PJ; Shapiro E; Whitley CB
    Mol Genet Metab; 2022 May; 136(1):22-27. PubMed ID: 35304037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of somatic burden of disease with age and neuropsychological measures in attenuated mucopolysaccharidosis types I, II and VI.
    Ahmed A; Shapiro E; Rudser K; Kunin-Batson A; King K; Whitley CB
    Mol Genet Metab Rep; 2016 Jun; 7():27-31. PubMed ID: 27114913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment.
    Shapiro EG; Nestrasil I; Rudser K; Delaney K; Kovac V; Ahmed A; Yund B; Orchard PJ; Eisengart J; Niklason GR; Raiman J; Mamak E; Cowan MJ; Bailey-Olson M; Harmatz P; Shankar SP; Cagle S; Ali N; Steiner RD; Wozniak J; Lim KO; Whitley CB
    Mol Genet Metab; 2015; 116(1-2):61-8. PubMed ID: 26095521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II.
    Shapiro EG; Rudser K; Ahmed A; Steiner RD; Delaney KA; Yund B; King K; Kunin-Batson A; Eisengart J; Whitley CB
    Mol Genet Metab Rep; 2016 Jun; 7():32-9. PubMed ID: 27114914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early disease progression of Hurler syndrome.
    Kiely BT; Kohler JL; Coletti HY; Poe MD; Escolar ML
    Orphanet J Rare Dis; 2017 Feb; 12(1):32. PubMed ID: 28193245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome.
    Eisengart JB; Jarnes J; Ahmed A; Nestrasil I; Ziegler R; Delaney K; Shapiro E; Whitley C
    Mol Genet Metab Rep; 2017 Dec; 13():64-68. PubMed ID: 28983455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation.
    Bjoraker KJ; Delaney K; Peters C; Krivit W; Shapiro EG
    J Dev Behav Pediatr; 2006 Aug; 27(4):290-6. PubMed ID: 16906003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open issues in Mucopolysaccharidosis type I-Hurler.
    Parini R; Deodato F; Di Rocco M; Lanino E; Locatelli F; Messina C; Rovelli A; Scarpa M
    Orphanet J Rare Dis; 2017 Jun; 12(1):112. PubMed ID: 28619065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II.
    Yund B; Rudser K; Ahmed A; Kovac V; Nestrasil I; Raiman J; Mamak E; Harmatz P; Steiner R; Lau H; Vekaria P; Wozniak JR; Lim KO; Delaney K; Whitley C; Shapiro EG
    Mol Genet Metab; 2015 Feb; 114(2):170-7. PubMed ID: 25541100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An online survey on burden of illness among families with post-stem cell transplant mucopolysaccharidosis type I children in the United States.
    Conner T; Cook F; Fernandez V; Rascati K; Rangel-Miller V
    Orphanet J Rare Dis; 2019 Feb; 14(1):48. PubMed ID: 30777108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucopolysaccharidosis I; Parental beliefs about the impact of disease on the quality of life of their children.
    Soni-Jaiswal A; Mercer J; Jones SA; Bruce IA; Callery P
    Orphanet J Rare Dis; 2016 Jul; 11(1):96. PubMed ID: 27406185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I.
    Pastores GM; Arn P; Beck M; Clarke JT; Guffon N; Kaplan P; Muenzer J; Norato DY; Shapiro E; Thomas J; Viskochil D; Wraith JE
    Mol Genet Metab; 2007 May; 91(1):37-47. PubMed ID: 17336562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis.
    Matsubara Y; Miyazaki O; Kosuga M; Okuyama T; Nosaka S
    Pediatr Radiol; 2017 Nov; 47(12):1659-1669. PubMed ID: 28733853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The development of cognitive functions in children with Hurler phenotype mucopolysaccharidosis type I on enzyme replacement therapy with laronidase].
    Biernacka M; Jakubowska-Winecka A; Tylki-SzymaƄska A
    Pediatr Endocrinol Diabetes Metab; 2010; 16(4):249-54. PubMed ID: 21447265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carpal tunnel syndrome in mucopolysaccharidosis I: a registry-based cohort study.
    Viskochil D; Muenzer J; Guffon N; Garin C; Munoz-Rojas MV; Moy KA; Hutchinson DT
    Dev Med Child Neurol; 2017 Dec; 59(12):1269-1275. PubMed ID: 28892147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected coronary artery findings in mucopolysaccharidosis. Report of four cases and literature review.
    Braunlin E; Orchard PJ; Whitley CB; Schroeder L; Reed RC; Manivel JC
    Cardiovasc Pathol; 2014; 23(3):145-51. PubMed ID: 24508139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the shortened Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS).
    Mattera M; Vernon MK; Raluy-Callado M; Mikl J
    Health Qual Life Outcomes; 2018 Nov; 16(1):209. PubMed ID: 30409228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Cognitive and Functional Outcomes in Children with Mucopolysaccharidosis (MPS)-IH (Hurler Syndrome) Treated with Hematopoietic Cell Transplantation.
    Kunin-Batson AS; Shapiro EG; Rudser KD; Lavery CA; Bjoraker KJ; Jones SA; Wynn RF; Vellodi A; Tolar J; Orchard PJ; Wraith JE
    JIMD Rep; 2016; 29():95-102. PubMed ID: 26825088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
    Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
    Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.